Public directory / Facility profile

Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, Irving

TX · FDA-registered outsourcing facility (503B). A factual public-record profile built from FDA sources, with dates. It is not a ranking, grade, or endorsement.

What the public record shows

FDA 503B registration status

FDA 503B list ✓ (current 2026-08-10)

Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, Irving appears on FDA's registered outsourcing facilities list, parsed from Veritura's capture of that list (FDA list current as of 2026-08-10, captured 2026-08-16). Registration status can change between captures; the FDA page is the authoritative current source.

On our captures

On FDA's list since we began tracking captures on 2026-07-11 (tracking began 2026-07-10; we make no claim about FDA's list before our first capture). Last confirmed on our 2026-08-11 capture (FDA list current as of 2026-08-10).

Dates are Veritura's own capture dates of FDA's public list, shown next to FDA's list-current date wherever we have it. Public-record posture, not a determination.

FDA enforcement timeline

Live check unavailable, treated as not checked. This timeline shows a completed live read of openFDA or none at all; it never substitutes a cached guess. Try again shortly, or query openFDA directly.

Live FDA enforcement screen

Live FDA enforcement screen unavailable right now. This profile shows a live result or none at all; it never substitutes a cached guess. Try again shortly, or check openFDA directly.

Reported products

24 distinct products as reported to FDA in 503B product reports (data vintage: reporting periods 2026-1, 2025-2); 20 shown.

  • Anastrozole; Testosterone · 4 mg; 75 mg · pellet · reported period 2026-1
  • Estradiol · 6 mg · pellet · reported period 2026-1
  • Estradiol · 18 mg · pellet · reported period 2026-1
  • Estradiol · 50 mg · pellet · reported period 2026-1
  • Estradiol · 10 mg · pellet · reported period 2026-1
  • Estradiol · 12.5 mg · pellet · reported period 2026-1
  • Estradiol · 25 mg · pellet · reported period 2026-1
  • Estradiol · 37.5 mg · pellet · reported period 2026-1
  • Estradiol · 15 mg · pellet · reported period 2026-1
  • Testosterone · 12.5 mg · pellet · reported period 2026-1
  • Testosterone · 100 mg · pellet · reported period 2026-1
  • Testosterone · 37.5 mg · pellet · reported period 2026-1
  • Testosterone · 50 mg · pellet · reported period 2026-1
  • Testosterone · 87.5 mg · pellet · reported period 2026-1
  • Testosterone · 200 mg · pellet · reported period 2026-1
  • Testosterone · 25 mg · pellet · reported period 2026-1
  • Testosterone Cypionate · .2 g · injection · reported period 2026-1
  • Testosterone Cypionate; Testosterone Propionate · 200 mg/1 mL; 10 mg/1 mL · solution · reported period 2026-1
  • Anastrozole; 1-Testosterone · 4 mg; 100 mg · pellet · reported period 2025-2
  • Estradiol · 20 mg · pellet · reported period 2025-2

Source: FDA outsourcing facility product reports (FD&C 503B(b)(2)). Retrospective by design: a row means the facility reported compounding this product to FDA in the named period, never that it currently compounds, can supply, or is endorsed for it. Public-record posture, not a determination.

Watch this facility

Get an email if this facility's FDA list status or enforcement record changes between our captures. Public-record change notices only; every email carries a one-click unsubscribe link.

Is this your facility?

Claim this profile to keep it accurate and attach your own documentation through Veritura. Every claim is verified by hand before anything changes.

Documented public status from FDA sources. Not an approval, ranking, or endorsement. Veritura does not rank facilities. Dates below show when FDA's list was current and when we captured it, not a Veritura verification of any facility.